4 - 5 October 2022
Insight - Access - Engagement
Innovation & Partnering at the confluence of Neuroscience & Mental Health with Artificial Intelligence & Digital.
Calling all neuroscience, psychiatry and digital health innovation-leaders, decision-makers & KOLs, from all stakeholder groups, to join an open format, high-engagement, interactive, cross industry, multi-disciplinary summit of roundtable discussions on meeting both the challenges and the opportunities in brain health innovation.
In-Person at the Champalimaud Foundation in Lisbon.
Digital Partnering takes place subsequently, Nov. 28 - Dec. 2, for 5 full days of premium digital partnering in a dedicated stream with a global network on the BiotechGate Digital Partnering Platform. This approach is designed to maximize partnering opportunities without missing out on the in-person networking and program sessions.
Driving meaningful innovation, impact, improved healthcare and patient outcomes, and value creation in the confluence of research and innovation in mental health, neuroscience, artificial intelligence and digital health.
From A.I. enabled drug discovery and development, big data, digital biomarkers, Real World Data and trial design. From advanced imaging, companion digital health and connected health, to neuromodulation, V.R. and cognitive behavioral therapy. And from improved early diagnosis, imaging, sensors, monitoring and delivery of care, to true digital therapeutics. The pace of innovation is unprecedented, the paradigms are changing, and the potential for positive impact on patient outcomes and quality of life, improved delivery of care, healthcare expenditure, and societal benefit are enormous.
The Neuro, Digital & A.I. Innovation Summit is organized by Broadreach Global and Hosted by the Champalimaud Foundation, with Partners the European Brain Council (EBC), and the support of our Global Innovation Partners and other key stakeholder organizations.
Hear from key opinion leaders, innovators, entrepreneurs and decision-makers from healthcare, finance, and the pharma, technology, medtech and healthech industries.
Catch keynotes on key technologies, applications and issues, and join panel discussions on opportunities and challenges.
Find out first hand the visions, innovation and partnering interests of industry leaders.
Connect with leading investors and understand their focus, investment interests, processes and criteria.
What are the applications of A.I. and digital in mental health & neurosciences, going beyond wellness, to drug discovery and development, personalized medicine and trial design, CBT, neuromodulation, advanced medical imaging, from mental illness to chronic disease and rare disorders.
What solutions can technology transfer from the world-leading institutions and most innovative private companies provide?
What business models & treatment paradigms hold promise, where are the real challenges, what needs to be revisited, and what are the paths forward?
What cross-stakeholder collaboration is needed to address challenges, drive real results and achieve the true potential impact, and how do we build those collaborations? How does this apply to your own team?
Understanding the startup journey and path to market, what are the challenges and how can common pitfalls be avoided and risks managed?
Which partners can provide the expertise to move these innovations to the market?
Network, Connect & Partner with
- Neurologists, Psychiatrists & Clinicians
- Researchers & Engineers & Entrepreneurs
- Neuro, C.B.T., A.I. & Digital Health KOLs
- University & Institute Tech Transfer
- Spinouts & Startups
- Growth Companies
- Pharma Neuro, CNS & Neuro Digital
- Tech, MedTech & HealthTech Industry
- Venture Capital, Corporate & Angel Investors
- Public funding Bodies
- Health Systems
- Patient Organizations, Foundations & Charities
Pawel Swieboda, Director General - Human Brain Project, and CEO - EBRAINS
Andy Keller, President & CEO, Meadows Mental Health Policy Institute, Texas
Maneesh Juneja, Digital Health Futurist
Nick Taptiklis, Head of Technology Strategy, Cambridge Cognition
Pamela Tenaerts, Chief Scientific Officer, Medable
Joachim Scholpp, Global Head Translational Medicine, CNS, Retinal Health & Emerging Areas, Boehringer Ingelheim
Solome Tibebu, Founder, Going Digital Behavioral Health Tech
John Krakauer, Professor of Neurology, Neuroscience, and Physical Medicine & Rehabilitation, Johns Hopkins School of Medicine
Harris Eyre MD PhD, Lead, Brain Capital Alliance. Co-founder, PRODEO Institute
Shwen Gwee, Digital Health & Corporate Innovation Executive, ex BMS Global Head of Digital Strategy, ex-Novartis BIOME & Open Innovation co-founder
Paulo Machado, CEO/Founder Health Innovation Partners
Mark Treherne, Chairperson Monument Therapeutics
Vreni Schoenenberger, Global Franchise Head, External Affairs /Partnership Strategy, Novartis
Juan Carlos Lopez, Managing Director, Research Grants, RTW Charitable Foundation
Beth Wolff, Director Digital Health Solutions, BD&L Search & Assessment, Lundbeck A/S
Naomi Glover, Co-Founder/Director, Applied Neuroscience Association
James W. Bair, Managing Director/Partner, Baraka Impact Finance
Joe Paton, Director of Neuroscience & Principal Investigator, Champalimaud Foundation
Vaibhav A Narayan, Executive Vice President & Head of Strategy & Innovation, Davos Alzheimer’s Collaborative (DAC)
Karl Nägler, Managing Partner, Wellington Partners Life Sciences
Beth Shafer, Vice President & Head, Business Development, Takeda (to be confirmed)
Ana Maicques, CEO & Co-Founder, Neuroelectrics
Amit Khanna, Global Program Head, Parkinson’s & Neuroscience Digital Programs, Novartis
Matthieu Vallin, Vice President, Digital Health Innovation, Octopus Ventures
Eduardo Emrich Soares, Operating Partner, Zentynel Frontier Investments Brazil/Chile
Frédéric Destrebecq, Executive Director, European Brain Council (EBC)
João Bocas, The Wearables Expert, Digital Health Influencer, CEO, Digital Salutem
Katrina Laks, Co-Founder & CEO, Migrevention
Karl Hess, Managing Director, Outcome Capital
Hana Besbes, Investor, Heal Capital
Junaid Bajwa, Chief Medical Scientist, Microsoft (to be confirmed)
Julia Prakapovich, Partner, InterFace Fund (to be confirmed)
Christian J. Suojanen, CEO - Broadreach Global, Member of the Executive Board - European Brain Foundation